Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution

Optimized anion exchange column isolation of zirconium-89 ( 89 Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform

(2018) Matthew J. O’Hara et al.   JOURNAL OF CHROMATOGRAPHY A

Evaluation of a chloride-based 89 Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin

(2018) Stephen A. Graves et al.   NUCLEAR MEDICINE AND BIOLOGY

Stability Constants for Zirconium(IV) Complexes with EDTA, CDTA, and DTPA in Perchloric Acid Solutions

(2018) Mitchell T. Friend et al.   INORGANICA CHIMICA ACTA

A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography

(2017) Nan Li et al.   International Journal of Nanomedicine

Production and radiochemical separation of a potential immuno-PET imaging agent 89Zr from proton irradiated natY target

(2017) Sujata Saha Das et al.   JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

Metal-Based PSMA Radioligands

(2017) Eleni Gourni et al.   MOLECULES

Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89

(2017) Nikunj B. Bhatt et al.   PLoS One

Clinical Applications of Radiolabeled Peptides for PET

(2017) Isaac M. Jackson et al.   SEMINARS IN NUCLEAR MEDICINE

Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development

(2017) Darpan N. Pandya et al.   Chemical Science

A simple and convenient method for production of 89 Zr with high purity

(2016) Yu Tang et al.   APPLIED RADIATION AND ISOTOPES

Bone Marrow Cell Trafficking Analyzed by 89 Zr-oxine Positron Emission Tomography in a Murine Transplantation Model

(2016) Kingsley O. Asiedu et al.   CLINICAL CANCER RESEARCH

The next generation of positron emission tomography radiopharmaceuticals labeled with non-conventional radionuclides

(2016) Raisa N. Krasikova et al.   MENDELEEV COMMUNICATIONS

Evaluation of [89Zr]-Oxalate as a PET Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models

(2016) Ji-Ae Park et al.   MOLECULAR PHARMACEUTICS

Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice

(2016) Jeff N.Tinianow et al.   Theranostics

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

(2016) Yvonne W. S. Jauw et al.   Frontiers in Pharmacology

Radiometals: towards a new success story in nuclear imaging?

(2015) David Brasse et al.   DALTON TRANSACTIONS

Recent advances of injectable radiopharmaceuticals for nuclear imaging and therapy: a new era in nuclear medicine

(2015) Zhengtao Qin   MATERIALS TECHNOLOGY

Preparation and preclinical evaluation of 66Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical

(2015) V. Lopez-Rodriguez et al.   NUCLEAR MEDICINE AND BIOLOGY

PET imaging with the non-pure positron emitters: 55Co, 86Y and 124I

(2015) P E N Braad et al.   PHYSICS IN MEDICINE AND BIOLOGY

89Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies

(2015) Noriko Sato et al.   RADIOLOGY

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

(2015) Brian M. Zeglis et al.   Jove-Journal of Visualized Experiments

Novel 89Zr cell labeling approach for PET-based cell trafficking studies

(2015) Aditya Bansal et al.   EJNMMI Research

44Sc: An Attractive Isotope for Peptide-Based PET Imaging

(2014) Reinier Hernandez et al.   MOLECULAR PHARMACEUTICS

Prospective of 68Ga-Radiopharmaceutical Development

(2014) Irina Velikyan   Theranostics

The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu

(2014) Artor Niccoli Asabella et al.   Biomed Research International

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients

(2014) Floor C. J. van de Watering et al.   Biomed Research International

Clinical applications of Gallium-68

(2013) Sangeeta Ray Banerjee et al.   APPLIED RADIATION AND ISOTOPES

Matching chelators to radiometals for radiopharmaceuticals

(2013) Eric W. Price et al.   CHEMICAL SOCIETY REVIEWS

89Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals

(2013) Danielle J. Vugts et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges

(2013) Gabriel Fischer et al.   MOLECULES

Zirconium Solubility in Ternary Aqueous System of Zr(IV)-OH-Carboxylates

(2012) Taishi KOBAYASHI et al.   JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY

PET imaging with 89Zr: From radiochemistry to the clinic

(2012) Melissa A. Deri et al.   NUCLEAR MEDICINE AND BIOLOGY

Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen

(2012) David Ulmert et al.   Cancer Discovery

In vivo biodistribution and accumulation of 89Zr in mice

(2011) Diane S. Abou et al.   NUCLEAR MEDICINE AND BIOLOGY

Production of 88,89Zr by proton induced activation of natY and separation by SLX and LLX

(2009) Binita Dutta et al.   JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

Standardized methods for the production of high specific-activity zirconium-89

(2009) Jason P. Holland et al.   NUCLEAR MEDICINE AND BIOLOGY

Proton induced reactions on 89Y with particular reference to the production of the medically interesting radionuclide 89Zr

(2009) H. M. Omara et al.   RADIOCHIMICA ACTA